13 Results for "

Cripto

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "Cripto" in MCE Product Catalog:

Cat. No.: HY-RS16445
Research Areas:  

Others

TDGF1P3 Human Pre-designed siRNA Set A contains three designed siRNAs for TDGF1P3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-P85107
Synonyms: TDGF1; Cripto; Teratocarcinoma-derived growth factor 1; Cripto-1 growth factor; CRGF; Epidermal growth factor-like Cripto protein CR1

Host:  

Mouse

Application:  

WB, ELISA

Reactivity:  

Human

Cat. No.: HY-P75329
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: CFC-2; CR; Cripto; Cripto-1 growth factor; Cripto-1; TDGF1
Species:  
Rat
Source:  
Cat. No.: HY-P75330
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CFC-2; CR; Cripto; Cripto-1 growth factor; Cripto-1; TDGF1
Species:  
Rat
Source:  
Cat. No.: HY-P71112
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Teratocarcinoma-derived growth factor 1; Cripto-1 growth factor; CRGF; Epidermal growth factor-like Cripto protein CR1; TDGF1; Cripto
Species:  
Source:  
Cat. No.: HY-P703895
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Teratocarcinoma-derived growth factor 1; Cripto-1 growth factor; CRGF; Epidermal growth factor-like Cripto protein CR1; TDGF1; Cripto
Species:  
Source:  
Cat. No.: HY-P82500
Synonyms: CRGF; Cripto 1; Cripto; Cripto1 growth factor; TDGF1

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, FC

Reactivity:  

Human

Cat. No.: HY-P702506
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CFC-2; CR; Cripto; Cripto-1 growth factor; Cripto-1; CriptoCRGF; Epidermal growth factor-like Cripto protein CR1; TDGF1; TDGF-1; teratocarcinoma-derived growth factor 1
Species:  
Source:  
Cat. No.: HY-P700481
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Cripto-1 growth factor ; CRGFEpidermal growth factor-like Cripto protein CR1
Species:  
Source:  
Cat. No.: HY-P700489
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Cripto-3 growth factor (Epidermal growth factor-like Cripto protein CR3); Teratocarcinoma-derived growth factor 1 pseudogene 3; Cripto3; TDGF2; TDGF3
Species:  
Source:  
Cat. No.: HY-10321G
CAS No.: 219580-11-7
PD173074 GMP is PD173074 (HY-10321) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. PD173074 is an orally active FGFR inhibitor that targets the transphosphorylation of FGFR1 and FGFR2 and blocks the FGF signaling pathway. By reducing the phosphorylation level of SMAD2 and altering the expression of Nodal/Activin target genes, PD173074 eliminates endothelial differentiation potential, thereby inhibiting the formation of capillary-like structures. PD173074 blocks the proliferation and colony formation of tumor cells and increases intratumoral cell apoptosis. PD173074 successfully reverses FGF-2-induced chemoresistance to enhance the effect of cisplatin (HY-17394) in small cell lung cancer models. PD173074 can be applied to research related to critical limb ischemia and small cell lung cancer .
Cat. No.: HY-P78521
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CD172g; FLJ42230; SIRP beta 2; SIRP gamma; SIRP-B2; SIRPG; Cripto-1; bA77C3.1; SIRP β 2
Species:  
Source:  
Cat. No.: HY-P78210
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CD172g; FLJ42230; SIRP beta 2; SIRP gamma; SIRP-B2; SIRPG; Cripto-1; bA77C3.1; SIRP β 2
Species:  
Source:  
  • 1